Article
Environmental Sciences
Bijo Mathew, Jong Min Oh, Roua S. Baty, Gaber El-Saber Batiha, Della Grace Thomas Parambi, Nicola Gambacorta, Orazio Nicolotti, Hoon Kim
Summary: The study evaluated eleven piperazine-containing derivatives for their inhibitory activities against MAOs, ChEs, and BACE-1, with compounds PC10 and PC11 showing significant inhibitory effects on MAO-B. Compound PC3 effectively inhibited BACE-1, suggesting that PC10 and PC11 could be potential candidates for the treatment of neurological disorders.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
(2021)
Article
Biochemistry & Molecular Biology
Jacqueline Heger, Tamara Szabados, Paulin Brosinsky, Peter Bencsik, Peter Ferdinandy, Rainer Schulz
Summary: The knockout of monoamine oxidase (MAO)-B specifically in cardiomyocytes reduces myocardial ischemia/reperfusion (I/R) injury in vitro. In this study, the researchers investigated the impact of MAO-B knockout on myocardial infarction (MI) following I/R in male and female mice. They found that MAO-B knockout protected male mice against MI, but had no effect on infarct size in female mice.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemical Research Methods
Clement Agoni, Abdul Rashid Issahaku, Mohamed A. Abdelgawad, Ahmed Khames, Mahmoud E. S. Soliman, Bijo Mathew
Summary: This study employs molecular dynamics simulations to investigate the impact of extended double bond conjugation on the inhibition of MAO-B protein. The results reveal that extended double bond conjugation stabilizes the binding pocket and inhibits the motion of residues within the pocket. Additionally, the extended double bond conjugation mediates unique interactions with binding pocket residues, leading to higher binding affinities of F1 and MO10.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
(2022)
Article
Biochemistry & Molecular Biology
Liliana Pacureanu, Alina Bora, Luminita Crisan
Summary: In order to discover new MAO-B inhibitors, we developed a comprehensive computational approach including a pharmacophoric atom-based 3D QSAR model, activity cliffs analysis, fingerprint analysis, and molecular docking analysis. The AAHR.2 hypothesis provided a statistically significant 3D QSAR model, and hydrophobic and electron-withdrawing fields revealed the relationship between structural characteristics and inhibitory activity. The quinolin-2-one scaffold played a key role in selectivity towards MAO-B. Molecular docking analysis confirmed the interactions with crucial residues responsible for MAO-B activity. The computational scenario presented here will assist chemists in designing and predicting new potent and selective MAO-B inhibitors.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Mohamed H. Elsherbeny, Jushin Kim, Noha A. Gouda, Lizaveta Gotina, Jungsook Cho, Ae Nim Pae, Kyeong Lee, Ki Duk Park, Ahmed Elkamhawy, Eun Joo Roh
Summary: A series of novel indole-based small molecules were synthesized as MAO-B inhibitors, with compounds 7b, 8a, 8b, and 8e showing excellent inhibitory effects and selectivity indices, potentially counteracting oxidative stress and displaying safe neurotoxicity profiles in PC12 cells.
Article
Biochemistry & Molecular Biology
Jong Min Oh, Hyun-Jae Jang, Myung-Gyun Kang, Seul-Ki Mun, Daeui Park, Su-Jin Hong, Min Ha Kim, Soo-Young Kim, Sung-Tae Yee, Hoon Kim
Summary: Thirteen compounds were isolated from Canavalia lineata pods and their inhibitory activities against hMAO-A and -B were evaluated. Compounds 8 and 13 showed potent inhibitory activity against hMAO-B, while most compounds weakly inhibited MAO-A. Compounds 8 and 13 were reversible competitive inhibitors against hMAO-B.
Article
Biochemistry & Molecular Biology
Sunil Kumar, Jayalakshmi Jayan, Amritha Manoharan, Feba Benny, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Mohamed El-Sherbiny, Sachithra Thazhathuveedu Sudevan, T. P. Aneesh, Bijo Mathew
Summary: Nearly one billion people worldwide suffer from neurological disorders, posing significant public health challenges. Monoamine oxidase (MAO), a crucial enzyme in numerous neurodegenerative diseases, requires more understanding of its precise structural requirements for effective treatment despite the recent examination of potential drugs. This study employs atom-based, field-based, and GA-MLR models to investigate this matter, all of which demonstrate strong statistical foundations. By comparing to a well-known MAO-B inhibitor, safinamide, our dataset's molecule exhibits a higher docking score. Further utilization of the SwissSimilarity platform identifies ZINC000016952895 as the most suitable compound for screening, based on its best binding docking score (XP score = -13.3613). Molecular dynamics (MD) investigations confirm the stability of the ZINC000016952895-MAO-B complex over 100 ns. In addition, ADME properties of the hit compounds are anticipated. The successful compound ZINC000016952895 discovered in this research holds potential for future MAO inhibitors in treating neurological diseases.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2023)
Article
Biochemistry & Molecular Biology
Magdalena Kondeva-Burdina, Javor Mitkov, Iva Valkova, Lily Peikova, Maya Georgieva, Alexander Zlatkov
Summary: The neurotoxic, neuroprotective, and MAO-B inhibitory effects of a series of N'-substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazides were evaluated. Compounds N'-(2,3-dimethoxybenzylidene)-3-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio)propanehydrazide (6k) and N'-(2-hydroxybenzylidene)-3-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio)propanehydrazide (6l) were identified as the most promising. QSTR analysis revealed that reduced lipophilicity and smaller dipole moments of the molecules contribute to lower neurotoxicity. These findings provide initial information for the further design of (xanthinyl-8-ylthio)propanhydrazides with potential hMAOB inhibitory effect and pronounced neuroprotection.
Review
Chemistry, Multidisciplinary
Pratibha Sharma, Manjinder Singh, Bijo Mathew
Summary: The design and development of various classes of MAO-B inhibitors are considered effective adjuvant therapies for various neurodegenerative disorders. Recent studies suggest the introduction of an electron rich linker between two aryl or heteroaryl rings as a promising structural framework for MAO-B inhibition. The current review focuses on the design aspects, synthetic routes, and structure-activity relationships of various classes of selective MAO-B inhibitors.
Review
Biochemistry & Molecular Biology
Bijo Mathew, Simone Carradori, Paolo Guglielmi, Md Sahab Uddin, Hoon Kim
Summary: The use of halogens in drug structures plays a significant role in modulating their physical-chemical properties and enzymatic selectivity, especially through the formation of halogen bonds at active sites. This review highlights the impact of halogens on Monoamine Oxidase activity and isozyme selectivity.
CURRENT MEDICINAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Ahmed Elkamhawy, Hyeon Jeong Kim, Mohamed H. Elsherbeny, Sora Paik, Jong-Hyun Park, Lizaveta Gotina, Magda H. Abdellattif, Noha A. Gouda, Jungsook Cho, Kyeong Lee, Ae Nim Pae, Ki Duk Park, Eun Joo Roh
Summary: This study reported the design and synthesis of twenty-six new indole derivatives as potential MAO-B inhibitors, with compound 5 showing high inhibitory activity against hMAO-B and good selectivity index. The compound also demonstrated low cytotoxicity, promising neuroprotective effect, and high CNS bioavailability, making it a potent candidate for PD treatment.
BIOORGANIC CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Ying-Da Feng, Wen Ye, Wen Tian, Jing-Ru Meng, Meng Zhang, Yang Sun, Hui-Nan Zhang, Shou-Jia Wang, Ke-Han Wu, Chen-Xu Liu, Shao-Yuan Liu, Wei Cao, Xiao-Qiang Li
Summary: This study investigated the effects of APG on intestinal ischemia/reperfusion injury (IIRI). The results showed that APG could improve intestinal edema and increase Chiu's score. It was found that APG specifically bound to heme oxygenase 1 (HO-1) and monoamine oxidase b (MAO-B), and could attenuate ROS generation and Fe2+ accumulation, maintain mitochondria function, and inhibit ferroptosis in a dose-dependent manner. In addition, knocking down HO-1 and MAO-B, as well as using their inhibitors, also had positive effects on intestine and vascular endothelial cells.
FREE RADICAL BIOLOGY AND MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Linfeng Zheng, Xiangyang Qin, Jiao Wang, Mengying Zhang, Quanlin An, Jinzhi Xu, Xiaosheng Qu, Xin Cao, Bing Niu
Summary: This study used machine learning approaches to investigate the identification model of MAO-B inhibitors and demonstrated the high accuracy of the model through experimental validation. Furthermore, the research also explored the activity prediction model of MAO-B and analyzed the interaction between MAO-B and inhibitors using molecular docking.
Article
Chemistry, Analytical
S. Hoefs, T. Greiner, G. Goebel, A. Talke, F. Lisdat
Summary: The newly developed sensorial Mao B activity determination system quantifies enzyme activity by electrochemical detection of enzymatically produced H2O2, showing potential for personalized treatment of Parkinson's disease.
SENSORS AND ACTUATORS B-CHEMICAL
(2021)
Article
Biochemistry & Molecular Biology
Yassir Boulaamane, Iqrar Ahmad, Harun Patel, Niloy Das, Mohammed Reda Britel, Amal Maurady
Summary: Coumarins connected to position 6 exhibit higher selectivity towards MAO-B, while those connected to position 7 are relatively unstable. Molecular docking and dynamics simulations can help in elucidating the molecular interactions responsible for this selectivity, providing insights for further drug development against Parkinson's disease.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2023)
Article
Chemistry, Medicinal
Anton Shetnev, Angelina Osipyan, Sergey Baykov, Alexander Sapegin, Zhanna Chirkova, Michail Korsakov, Anel Petzer, Idalet Engelbrecht, Jacobus P. Petzer
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2019)
Article
Biochemistry & Molecular Biology
Annah N. Mpitimpiti, Jacobus P. Petzer, Anel Petzer, Johannes H. L. Jordaan, Anna C. U. Lourens
MOLECULAR DIVERSITY
(2019)
Article
Biochemistry & Molecular Biology
Daniela Secci, Simone Carradori, Anel Petzer, Paolo Guglielmi, Melissa D'Ascenzio, Paola Chimenti, Donatella Bagetta, Stefano Alcaro, Gokhan Zengin, Jacobus P. Petzer, Francesco Ortuso
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
(2019)
Article
Biochemistry & Molecular Biology
Paolo Guglielmi, Simone Carradori, Giulio Poli, Daniela Secci, Roberto Cirilli, Giulia Rotondi, Paola Chimenti, Anel Petzer, Jacobus P. Petzer
Article
Biochemistry & Molecular Biology
Malikotsi A. Qhobosheane, Lesetja J. Legoabe, Anel Petzer, Jacobus P. Petzer
BIOORGANIC CHEMISTRY
(2019)
Article
Biochemistry & Molecular Biology
Lereze Marais, Anel Petzer, Jacobus P. Petzer, Lesetja J. Legoabe
MOLECULAR DIVERSITY
(2020)
Article
Chemistry, Medicinal
Zhanna Chirkova, Mariya Kabanova, Sergey Filimonov, Igor G. Abramov, Anel Petzer, Rialette Hitge, Jacobus P. Petzer, Kyrill Yu Suponitsky
DRUG DEVELOPMENT RESEARCH
(2019)
Article
Plant Sciences
Denise Prinsloo, Sandra van Dyk, Anel Petzer, Jacobus P. Petzer
Article
Biochemistry & Molecular Biology
Franciska de Beer, Jacobus P. Petzer, Anel Petzer
CHEMICAL BIOLOGY & DRUG DESIGN
(2020)
Article
Biochemistry & Molecular Biology
Johannie de Beer, Jacobus P. Petzer, Anna C. U. Lourens, Anel Petzer
Summary: The study focuses on developing non-nitrocatechol COMT inhibitors for the treatment of Parkinson's disease, aiming to prevent the metabolism of levodopa by COMT to enhance its effectiveness in the brain. By synthesizing a series of 3-hydroxypyridin-4-one compounds, it is demonstrated that they are potential inhibitors of COMT.
MOLECULAR DIVERSITY
(2021)
Article
Biochemistry & Molecular Biology
Malikotsi A. Qhobosheane, Lesetja J. Legoabe, Beatrice Josselin, Stephane Bach, Sandrine Ruchaud, Jacobus P. Petzer, Richard M. Beteck
BIOORGANIC & MEDICINAL CHEMISTRY
(2020)
Article
Pharmacology & Pharmacy
Louis Thesnaar, Jaco J. Bezuidenhout, Anel Petzer, Jacobus P. Petzer, Theunis T. Cloete
Summary: Research aimed to determine the minimum inhibitory concentration (MIC) of methylene blue and its analogues against several bacteria and fungi, and to develop and validate a common feature pharmacophore model to investigate the antimicrobial mode of action of methylene blue.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Stephanus J. Cloete, Clarina I. N'Da, Lesetja J. Legoabe, Anel Petzer, Jacobus P. Petzer
Summary: Monoamine oxidase (MAO) inhibitors play a significant role in the treatment of neuropsychiatric and neurodegenerative disorders, with this study identifying several potent compounds with high specificity for MAO-B inhibition. The most effective inhibitor was a 1-tetralone derivative with IC(50)values of 0.036 and 0.0011 mu M for MAO-A and MAO-B, respectively, highlighting its potential as a lead compound for future drug development.
MOLECULAR DIVERSITY
(2021)
Article
Biochemistry & Molecular Biology
Paolo Guglielmi, Daniela Secci, Ariel Petzer, Donatella Bagetta, Paola Chimenti, Giulia Rotondi, Claudio Ferrante, Lucia Recinella, Sheila Leone, Stefano Alcaro, Gokhan Zengin, Jacobus P. Petzer, Francesco Ortuso, Simone Carradori
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
(2019)
Article
Chemistry, Medicinal
F. P. Viljoen, J. L. du Preez, A. Petzer, J. C. Wessels, J. Petzer, M. E. Aucamp
Article
Chemistry, Medicinal
Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan
Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang
Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman
Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li
Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang
Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla
Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)